Effects of repeated methylphenidate treatment in the young rat: Sensitization of both locomotor activity and stereotyped sniffing

Experimental and Clinical Psychopharmacology

Volumn 7, Issue 3, 1999, Pages 208-218

  McDougall, Sanders A ^a   Collins, Robert L ^a   Karper, Patrick E ^a   Watson, Joseph B ^b   Crawford, Cynthia A ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DEXAMPHETAMINE; METHAMPHETAMINE; METHYLPHENIDATE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; ATTENTION DEFICIT DISORDER; CONCENTRATION RESPONSE; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIZATION; LOCOMOTION; NONHUMAN; RAT; SNIFFING; STEREOTYPY;

AGING; ANIMALS; DECEREBRATE STATE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HINDLIMB; MALE; MECHANORECEPTORS; METHYLPHENIDATE; MORPHINE; MOTOR ACTIVITY; NARCOTICS; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; STEREOTYPED BEHAVIOR; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0032784038     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.7.3.208     Document Type: Article

References (64)

1. Barkley, R. A., McMurray, M. B., Edelbrock, C. S., & Robbins, K. (1990). Side effects of methylphenidate in children with attention-deficit hyperactivity disorder: A systemic, placebo-controlled evaluation. Pediatrics, 86, 184-192.
2. Bergman, J., Madras, B., Johnson, S. E., & Spealman, R. D. (1989). Effects of cocaine and related drugs in nonhuman primates: III. Self administration by squirrel monkeys. Journal of Pharmacology and Experimental Therapeutics, 251, 150-155.
3. Borcherding, B. G., Keysor, C. S., Rapoport, J. L., Elia, J., & Amass, J. (1990). Motor/vocal tics and compulsive behaviors on stimulant drugs: Is there a common vulnerability? Psychiatry Research, 33, 83-94.
4. Bowman, B. P., Blatt, B., & Kühn, C. M. (1997). Ontogeny of the behavioral response to dopamine agonists after chronic cocaine. Psychopharmacology, 129, 121-127.
5. Callaway, C. W., Kuczenski, R., & Segal, D. S. (1989). Reserpine enhances amphetamine stereotypies without increasing amphetamine-induced changes in striatal dialysate dopamine. Brain Research, 505, 83-90.
6. Cameron, D. L., Crosbie, J., & Cracker, A. D. (1988). A fixed interval momentary sampling method for assessing on-going behaviours induced by dopamine receptor agonists. Progress in Neuropsychopharmacology and Biological Psychiatry, 12, 595-606.
7. Carter, H. S., & Watson, W. A. (1994). IV pentazocine/ methylphenidate abuse: The clinical toxicity of another Ts and blues combination. Journal of Toxicology and Clinical Toxicology, 32, 541-547.
8. Castañeda, E., Becker, J. B., & Robinson, T. E. (1988). The long-term effects of repeated amphetamine treatment in vivo on amphetamine, KC1 and electrical stimulation evoked striatal dopamine release in vitro. Life Sciences, 42, 2447-2456.
9. Castellanos, F. X., Giedd, J. N., Elia, J., Marsh, W. L., Ritchie, G. F., Hamburger, S. D., & Rapoport, J. L. (1997). Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: Effects of stimulant and dose. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 589-596.
10. Castro, R., Abreu, P., Calzadilla, C. H., & Rodriguez, M. (1985). Increased or decreased locomotor response in rats following repeated administration of apomorphine depends on dosage interval. Psychopharmacology, 85, 333-339.
11. Chiueh, C. C., & Moore, K. E. (1975a). Blockade by reserpine of methylphenidate induced release of brain dopamine. Journal of Pharmacology and Experimental Therapeutics, 193, 559-563.
12. Chiueh, C. C., & Moore, K. E. (1975b). d-Amphetamine-induced release of newly synthesized and stored dopamine from the caudate nucleus in vivo. Journal of Pharmacology and Experimental Therapeutics, 192, 642-653.
13. Crawford, C. A., McDougall, S. A., Meier, T. L., Collins, R. L., & Watson, J. B. (1998). Repeated methylphenidate treatment induces behavioral sensitization and decreases protein kinase A and dopamine-stimulated adenylyl cyclase activity in the dorsal striatum. Psychopharmacology, 136, 34-43.
14. Duke, M. A., O'Neal, J., & McDougall, S. A. (1997). Ontogeny of dopamine agonist-induced sensitization: Role of NMDA receptors. Psychopharmacology, 129, 153-160.
15. Fujiwara, Y., Kazahaya, Y., Nakashima, M., Sato, M., & Otsuki, S. (1987). Behavioral sensitization in the rat: An ontogenic study. Psychopharmacology, 91, 316-319.
16. Gadow, K. D., Sverd, J., Sprafkin, J., Nolan, E. E., & Ezor, S. N. (1995). Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder. Archives of General Psychiatry, 52, 444-455.
17. Gatley, S. J., Pan, D., Chen, R., Chaturvedi, G., & Ding, Y.-S. (1996). Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sciences, 58, PL 231-239.
18. Gaytan, O., al-Rahim, S., Swann, A., & Dafny, N. (1997). Sensitization to locomotor effects of methylphenidate in the rat. Life Sciences, 61, PL 101-107.
19. Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature, 379, 606-612.
20. Henry, D. J., & White, F. J. (1995). The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. Journal of Neuroscience, 15, 6287-6299.
21. Heyman, G. M. (1992). Effects of methylphenidate on response rate and measures of motor performance and reinforcement efficacy. Psychopharmacology, 109, 145-152.
22. Hurd, Y. L., & Ungerstedt, U. (1989). In vivo neurochemical profile of dopamine uptake inhibitors and releasers in rat caudateputamen. European Journal of Pharmacology, 166, 251-260.
23. Jaffe, S. L. (1991). Intranasal abuse of prescribed methylphenidate by an alcohol- and drug-abusing adolescent with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry, 30, 773-775.
24. Johnson, I. S. R., O'Malley, P., & Bechman, J. (1995). National survey results on drug use for the monitoring the future study, 1975-1994: Vol. 1. Secondary school students (NIH Publication No. 95-4026). Washington, DC: U.S. Department of Health and Human Services.
25. Kalivas, P. W., & Stewart, J. (1991). Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Research Reviews, 16, 223-244.
26. Klein, R. G., & Wender, P. (1995). The role of methylphenidate in psychiatry. Archives of General Psychiatry, 52, 429-433.
27. Koek, W., & Colpaert, F. C. (1993). Inhibition of methylphenidate-induced behaviors in rats: Differences among neuroleptics. Journal of Pharmacology and Experimental Therapeutics, 267, 181-191.
28. Kolta, M. G., Scalzo, F. M., Ali, S. F, & Holson, R. R. (1990). Ontogeny of the enhanced behavioral response to amphetamine in amphetamine-pretreated rats. Psychopharmacology, 100, 377-382.
29. Kuczenski, R., & Segal, D. S. (1997). Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: Comparison with amphetamine. Journal of Neurochemistry, 68, 2032-2037.
30. Levin, F. R., & Kleber, H. D. (1995). Attention-deficit hyperactivity disorder and substance abuse: Relationships and implications for treatment. Harvard Review of Psychiatry, 2, 246-258.
31. Lowe, T. L., Cohen, D. J., Detlor, J., Kremenitzer, M. W, & Shaywitz, B. A. (1982, March 26). Stimulant medications precipitate Tourette's syndrome. JAMA: Journal of the American Medical Association, 247, 1729-1731.
32. Martin-Iverson, M. T., Ortmann, R., & Fibiger, H. C. (1985). Place preference conditioning with methylphenidate and nomifensine. Brain Research, 332, 59-67.
33. McDougall, S. A., Duke, M. A., Bolanos, C. A., & Crawford, C. A. (1994). Ontogeny of behavioral sensitization in the rat: Effects of direct and indirect dopamine agonists. Psychopharmacology, 116, 483-490.
34. McNamara, C. G., Davidson, E. S., & Schenk, S. (1993). A comparison of the motor-activating effects of acute and chronic exposure to amphetamine and methylphenidate. Pharmacology Biochemistry and Behavior, 45, 729-732.
35. Musten, L. M., Firestone, P., Pisterman, S., Bennett, S., & Mercer, J. (1997). Effects of methylphenidate on preschool children with ADHD: Cognitive and behavioral functions. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 1407-1415.
36. Nolan, E. E., & Gadow, K. D. (1997). Children with ADHD and tic disorder and their classmates: Behavioral normalization with methylphenidate. Journal of the American Academy of Child and Adolescent Psychiatry, 36, 597-604.
37. Parker, E. M., & Cubeddu, L. X. (1988). Effects of d-amphetamine and dopamine synthesis inhibitors on dopamine and acetylcholine neurotransmission in the striatum: I. Release in the absence of vesicular transmitter stores. Journal of Pharmacology and Experimental Therapeutics, 237, 179-192.
38. Parran, T. V., & Jasinski, D. R. (1991). Intravenous methylphenidate abuse: Prototype for prescription drug abuse. Archives of Internal Medicine, 151, 781-783.
39. Patrick, S. L., Thompson, T. L., Walker, J. M., & Patrick, R. L. (1991). Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus. Brain Research, 538, 343-346.
40. Paulson, P. E., Camp, D. M., & Robinson, T. E. (1991). The time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology, 103, 480-492.
41. Paulson, P. E., & Robinson, T. E. (1995). Amphetamine-induced time-dependent sensitization of dopamine neurotransmission in the dorsal and ventral striatum: A microdialysis study in behaving rats. Synapse, 19, 56-65.
42. Pechnick, R., Janowsky, D. S., & Judd, L. (1979). Differential effects of methylphenidate and d-amphetamine on stereotyped behavior in the rat. Psychopharmacology, 65, 311-315.
43. Rappley, M. D. (1997). Safety issues in the use of methylphenidate: An American perspective. Drug Safety, 17, 143-148.
44. Rebec, G. V., & Segal, D. S. (1980). Apparent tolerance to some aspects of amphetamine stereotypy with long-term treatment. Pharmacology Biochemistry and Behavior, 75,793-797.
45. Richters, J. E., Arnold, L. E., Jensen, P. S., Abikoff, H., Conners, C. K., Greenhill, L. L., Hechtman, L., Hinshaw, S. P., Pelham, W. E., & Swanson, J. M. (1995). NIMH Collaborative Multisite Multimodal Treatment Study of Children With ADHD: I. Background and rationale. Journal of the American Academy of Child and Adolescent Psychiatry, 34, 987-1000.
46. Robinson, T. E., & Becker, J. B. (1986). Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis. Brain Research Reviews, 11, 157-198.
47. Robinson, T. E., & Berridge, K. C. (1993). The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Research Reviews, 18, 247-291.
48. Roffman, J. L., & Raskin, L. A. (1997). Stereotyped behavior: Effects of d-amphetamine and methylphenidate in the young rat. Pharmacology Biochemistry and Behavior, 58, 1095-1102.
49. Segal, D. S., & Kuczenski, R. (1987). Behavioral and neurochemical characteristics of stimulant-induced augmentation. Pharmacological Bulletin, 23, 417-124.
50. Segal, D. S., & Kuczenski, R. (1992). Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Research, 577, 351-355.
51. Snyder, K. J., Katovic, N. M., & Spear, L. P. (1998). Longevity of the expression of behavioral sensitization to cocaine in preweanling rats. Pharmacology Biochemistry and Behavior, 60, 909-914.
52. Spencer, T., Biederman, J., Wilens, T., Harding, M., O'Donnell, D., & Griffin, S. (1996). Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 409-432.
53. St. Dennis, C., & Synoground, G. (1996). Methylphenidate. Journal of School Nursing, 12, 5-11.
54. Szatmari, P., Offord, D. R., & Boyle, M. H. (1989). Ontario Child Health Study: Prevalence of attention deficit disorder with hyperactivity. Journal of Clinical Child Psychology and Psychiatry and Allied Disciplines, 30, 219-230.
55. Tirelli, E., & Ferrara, M. (1997). Neonatal and preweanling rats are able to express short-term behavioral sensitization to cocaine. European Journal of Pharmacology, 328, 103-114.
56. Ujike, H., Tsuchida, K., Akiyama, K., Fujiwara, Y., & Kuroda, S. (1995). Ontogeny of behavioral sensitization to cocaine. Pharmacology Biochemistry and Behavior, 50, 613-617.
57. Volkow, N. D., Ding, Y.-S., Fowler, J. S., Wang, G.-J., Logan, J., Gatley, J. S., Dewey, S., Ashby, C., Liebermann, J., Hitzemann, R., & Wolf, A. P. (1995). Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain. Archives of General Psychiatry, 52, 456-463.
58. Volkow, N. D., Wang, G.-J., Gatley, J. S., Fowler, J. S., Ding, Y.-S., Logan, J., Hitzemann, R., Angrist, B., & Liebermann, J. (1996). Temporal relationships between the pharmacokinetics of methylphenidate in the human brain and its behavioral and cardiovascular effects. Psychopharmacology, 123, 26-33.
59. Weiss, S. R. B., Post, R. M., Pert, A., Woodward, R., & Murman, D. (1989). Context-dependent cocaine sensitization: Differential effect of haloperidol on development versus expression. Pharmacology Biochemistry and Behavior, 34, 655-661.
60. Wilens, T. E., & Biederman, J. (1992). The stimulants. Psychiatric Clinics of North America, 15, 191-222.
61. Wise, R. A., & Bozarth, M. A. (1987). A psychomotor stimulant theory of addiction. Psychological Review, 94, 469-492.
62. Wolf, M. E., White, F. J., Nassar, R., Brooderson, R. J., & Khansa, M. R. (1993). Differential development of autoreceptor subsensitivity and enhanced dopamine release during amphetamine sensitization. Journal of Pharmacology and Experimental Therapeutics, 264, 249-255.
63. Wolraich, M. L., Lindgren, S., Stormquist, A., Milich, R., Davis, C., & Watson, D. (1990). Stimutant medication use by primary care physicians in the treatment of attention-deficit hyperactivity disorder. Pediatrics, 86, 95-100.
64. Wood, R. D., Tirelli, E., Snyder, K. J., Heyser, C. J., LaRocca, T. M., & Spear, L. P. (1998). Evidence for behavioral sensitization to cocaine in preweanling rat pups. Psychopharmacology, 138, 114-123.